The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Following a +6.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where BFLY advanced for three days, in 185 of 225 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 130 of 156 cases where BFLY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 83%.
The 10-day RSI Indicator for BFLY moved out of overbought territory on September 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 24 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 89%.
The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BFLY as a result. In 75 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
The Moving Average Convergence Divergence Histogram (MACD) for BFLY turned negative on October 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 36 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.
BFLY moved below its 50-day moving average on October 13, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BFLY crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 56%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BFLY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
BFLY broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.982) is normal, around the industry mean (2.923). P/E Ratio (-24.483) is within average values for comparable stocks, (2.388). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (16.556) is also within normal values, averaging (40.124).
The Tickeron Seasonality Score of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. BFLY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 52 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BFLY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
On October 15, 2026, the Stochastic Oscillator for NTRA moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 54 instances where the indicator left the oversold zone. In 48 of the 54 cases the stock moved higher in the following days. This puts the odds of a move higher at over 89%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on NTRA as a result. In 82 of 100 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
Following a +3.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where NTRA advanced for three days, in 245 of 308 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Aroon Indicator entered an Uptrend today. In 231 of 286 cases where NTRA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.
The 10-day RSI Indicator for NTRA moved out of overbought territory on October 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 25 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 66%.
The Moving Average Convergence Divergence Histogram (MACD) for NTRA turned negative on October 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 35 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NTRA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
NTRA broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (32.713) is normal, around the industry mean (64.450). NTRA's P/E Ratio (-306.207) is considerably lower than the industry average of (2.086). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (17.857) is also within normal values, averaging (9.775).
The Tickeron Profit vs. Risk Rating rating for this company is 8 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. NTRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
BFLY | NTRA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 71 | 86 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 15 Undervalued | 6 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 8 | |
SMR RATING 1..100 | 97 | 94 | |
PRICE GROWTH RATING 1..100 | 36 | 34 | |
P/E GROWTH RATING 1..100 | 52 | 92 | |
SEASONALITY SCORE 1..100 | 32 | 42 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NTRA's Valuation (6) in the Biotechnology industry is in the same range as BFLY (15) in the null industry. This means that NTRA’s stock grew similarly to BFLY’s over the last 12 months.
NTRA's Profit vs Risk Rating (8) in the Biotechnology industry is significantly better than the same rating for BFLY (100) in the null industry. This means that NTRA’s stock grew significantly faster than BFLY’s over the last 12 months.
NTRA's SMR Rating (94) in the Biotechnology industry is in the same range as BFLY (97) in the null industry. This means that NTRA’s stock grew similarly to BFLY’s over the last 12 months.
NTRA's Price Growth Rating (34) in the Biotechnology industry is in the same range as BFLY (36) in the null industry. This means that NTRA’s stock grew similarly to BFLY’s over the last 12 months.
BFLY's P/E Growth Rating (52) in the null industry is somewhat better than the same rating for NTRA (92) in the Biotechnology industry. This means that BFLY’s stock grew somewhat faster than NTRA’s over the last 12 months.
| BFLY | NTRA | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 89% | 2 days ago 66% |
| Stochastic ODDS (%) | 2 days ago 86% | 2 days ago 89% |
| Momentum ODDS (%) | 2 days ago 89% | 2 days ago 82% |
| MACD ODDS (%) | 2 days ago 80% | 2 days ago 70% |
| TrendWeek ODDS (%) | 2 days ago 87% | 2 days ago 82% |
| TrendMonth ODDS (%) | 2 days ago 84% | 2 days ago 83% |
| Advances ODDS (%) | 11 days ago 82% | 2 days ago 80% |
| Declines ODDS (%) | 2 days ago 89% | 9 days ago 76% |
| BollingerBands ODDS (%) | 2 days ago 87% | 2 days ago 58% |
| Aroon ODDS (%) | 2 days ago 83% | 2 days ago 81% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BFLY’s FA Score shows that 1 FA rating(s) are green while NTRA’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BFLY’s TA Score shows that 3 TA indicator(s) are bullish while NTRA’s TA Score has 4 bullish TA indicator(s).
BFLY (@Medical/Nursing Services) experienced а -6.58% price change this week, while NTRA (@Medical Specialties) price change was +4.72% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.58%. For the same industry, the average monthly price growth was -10.79%, and the average quarterly price growth was -10.51%.
The average weekly price growth across all stocks in the @Medical Specialties industry was -3.66%. For the same industry, the average monthly price growth was -7.04%, and the average quarterly price growth was +41.88%.
BFLY is expected to report earnings on Oct 29, 2026.
NTRA is expected to report earnings on Nov 05, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Medical Specialties (-3.66% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
A.I.dvisor indicates that over the last year, BFLY has been loosely correlated with PACB. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BFLY jumps, then PACB could also see price increases.
| Ticker / NAME | Correlation To BFLY | 1D Price Change % | ||
|---|---|---|---|---|
| BFLY | 100% | -2.87% | ||
| PACB - BFLY | 52% Loosely correlated | +9.18% | ||
| TXG - BFLY | 45% Loosely correlated | +5.78% | ||
| QSI - BFLY | 44% Loosely correlated | +6.03% | ||
| CERS - BFLY | 41% Loosely correlated | +3.46% | ||
| NTRA - BFLY | 38% Loosely correlated | +1.84% | ||
More | ||||
A.I.dvisor indicates that over the last year, NTRA has been loosely correlated with ADPT. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if NTRA jumps, then ADPT could also see price increases.
| Ticker / NAME | Correlation To NTRA | 1D Price Change % | ||
|---|---|---|---|---|
| NTRA | 100% | +1.84% | ||
| ADPT - NTRA | 55% Loosely correlated | +3.73% | ||
| NEO - NTRA | 54% Loosely correlated | +2.53% | ||
| GH - NTRA | 53% Loosely correlated | +2.50% | ||
| ISRG - NTRA | 53% Loosely correlated | -2.26% | ||
| TMO - NTRA | 48% Loosely correlated | +0.97% | ||
More | ||||